Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 67,602 | 51,882 | 79,743 | 227,648 | 45,157 |
| Marketable Securities | 284,367 | 301,696 | 297,046 | 183,983 | 143,555 |
| Receivables | 5,878 | 5,025 | 3,744 | 6,297 | N/A |
| TOTAL | $369,771 | $383,043 | $390,195 | $434,135 | $209,875 |
| Non-Current Assets | |||||
| PPE Net | 11,191 | 11,042 | 11,018 | 9,394 | 7,681 |
| Other Non-Current Assets | 88,230 | 90,948 | 92,770 | 32,040 | 34,500 |
| TOTAL | $99,421 | $101,990 | $103,788 | $41,434 | $42,181 |
| Total Assets | $469,192 | $485,033 | $493,983 | $475,569 | $252,056 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,277 | 752 | 2,422 | 6,474 | 5,990 |
| Accrued Expenses | 11,325 | 9,599 | 7,105 | 11,676 | 7,576 |
| TOTAL | $158,796 | $165,433 | $125,940 | $147,594 | $21,972 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 132,261 | 148,440 | 101,645 | 122,341 | N/A |
| Other Non-Current Liabilities | 60,321 | 62,431 | 65,624 | 9,122 | 17,530 |
| TOTAL | $68,036 | $72,937 | $161,135 | $98,363 | $17,530 |
| Total Liabilities | $226,832 | $238,370 | $287,075 | $245,957 | $39,502 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,601 | 33,368 | 33,271 | 33,197 | 33,076 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -194,970 | -185,426 | -220,887 | -194,959 | -188,285 |
| Other shareholders' equity | 195 | -496 | -1,005 | -642 | -2,057 |
| TOTAL | $242,360 | $246,663 | $206,908 | $229,612 | $212,554 |
| Total Liabilities And Equity | $469,192 | $485,033 | $493,983 | $475,569 | $252,056 |